Global Preventable Vaccines Market Insights, Forecast to 2025
SKU ID : QYR-14044586 | Publishing Date : 02-Apr-2019 | No. of pages : 142
Detailed TOC of Global Preventable Vaccines Market Insights, Forecast to 2025
Table of Contents1 Study Coverage
1.1 Preventable Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Preventable Vaccines Market Size Growth Rate by Product
1.4.2 Adult Preventable Vaccines
1.4.3 Pediatric Preventable Vaccines
1.5 Market by End User
1.5.1 Global Preventable Vaccines Market Size Growth Rate by End User
1.5.2 Bacterial Diseases
1.5.3 Virus Diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Preventable Vaccines Market Size
2.1.1 Global Preventable Vaccines Revenue 2014-2025
2.1.2 Global Preventable Vaccines Sales 2014-2025
2.2 Preventable Vaccines Growth Rate by Regions
2.2.1 Global Preventable Vaccines Sales by Regions
2.2.2 Global Preventable Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Preventable Vaccines Sales by Manufacturers
3.1.1 Preventable Vaccines Sales by Manufacturers
3.1.2 Preventable Vaccines Sales Market Share by Manufacturers
3.1.3 Global Preventable Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Preventable Vaccines Revenue by Manufacturers
3.2.1 Preventable Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Preventable Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Preventable Vaccines Price by Manufacturers
3.4 Preventable Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Preventable Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Preventable Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Preventable Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Preventable Vaccines Sales by Product
4.2 Global Preventable Vaccines Revenue by Product
4.3 Preventable Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Preventable Vaccines Breakdown Data by End User
6 North America
6.1 North America Preventable Vaccines by Countries
6.1.1 North America Preventable Vaccines Sales by Countries
6.1.2 North America Preventable Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Preventable Vaccines by Product
6.3 North America Preventable Vaccines by End User
7 Europe
7.1 Europe Preventable Vaccines by Countries
7.1.1 Europe Preventable Vaccines Sales by Countries
7.1.2 Europe Preventable Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Preventable Vaccines by Product
7.3 Europe Preventable Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Preventable Vaccines by Countries
8.1.1 Asia Pacific Preventable Vaccines Sales by Countries
8.1.2 Asia Pacific Preventable Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Preventable Vaccines by Product
8.3 Asia Pacific Preventable Vaccines by End User
9 Central & South America
9.1 Central & South America Preventable Vaccines by Countries
9.1.1 Central & South America Preventable Vaccines Sales by Countries
9.1.2 Central & South America Preventable Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Preventable Vaccines by Product
9.3 Central & South America Preventable Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Preventable Vaccines by Countries
10.1.1 Middle East and Africa Preventable Vaccines Sales by Countries
10.1.2 Middle East and Africa Preventable Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Preventable Vaccines by Product
10.3 Middle East and Africa Preventable Vaccines by End User
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Business Overview
11.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GlaxoSmithKline Preventable Vaccines Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck Preventable Vaccines Products Offered
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Preventable Vaccines Products Offered
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer Preventable Vaccines Products Offered
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Company Business Overview
11.5.3 Sanofi Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sanofi Preventable Vaccines Products Offered
11.5.5 Sanofi Recent Development
11.6 Takeda Pharmaceutical
11.6.1 Takeda Pharmaceutical Company Details
11.6.2 Company Business Overview
11.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Takeda Pharmaceutical Preventable Vaccines Products Offered
11.6.5 Takeda Pharmaceutical Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Company Business Overview
11.7.3 Abbott Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Abbott Preventable Vaccines Products Offered
11.7.5 Abbott Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Company Business Overview
11.8.3 Roche Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Roche Preventable Vaccines Products Offered
11.8.5 Roche Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 Company Business Overview
11.9.3 AstraZeneca Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 AstraZeneca Preventable Vaccines Products Offered
11.9.5 AstraZeneca Recent Development
11.10 Mitsubishi Tanabe Pharma
11.10.1 Mitsubishi Tanabe Pharma Company Details
11.10.2 Company Business Overview
11.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Products Offered
11.10.5 Mitsubishi Tanabe Pharma Recent Development
11.11 Lupin
11.12 Serum Institute of India
11.13 LG Life Sciences
11.14 S K Chemicals
11.15 Shenzhen Kangtai Biological Products
11.16 Sinovac Biotech
11.17 Janssen Pharmaceuticals
11.18 Crucell
11.19 Bavarian Nordic
11.20 Baxter
11.21 Bharat Biotech
11.22 Dynavax
11.23 Valeant Pharmaceuticals
11.24 Protein Sciences
11.25 Panacea Biotec
12 Future Forecast
12.1 Preventable Vaccines Market Forecast by Regions
12.1.1 Global Preventable Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Preventable Vaccines Revenue Forecast by Regions 2019-2025
12.2 Preventable Vaccines Market Forecast by Product
12.2.1 Global Preventable Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Preventable Vaccines Revenue Forecast by Product 2019-2025
12.3 Preventable Vaccines Market Forecast by End User
12.4 North America Preventable Vaccines Forecast
12.5 Europe Preventable Vaccines Forecast
12.6 Asia Pacific Preventable Vaccines Forecast
12.7 Central & South America Preventable Vaccines Forecast
12.8 Middle East and Africa Preventable Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Preventable Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global Preventable Vaccines Market Insights, Forecast to 2025
List of Tables and FiguresFigure Preventable Vaccines Product Picture
Table Preventable Vaccines Market Segments
Table Key Manufacturers Preventable Vaccines Covered
Table Global Preventable Vaccines Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Preventable Vaccines Sales Market Share by Product 2014-2025
Figure Adult Preventable Vaccines Product Picture
Table Major Manufacturers of Adult Preventable Vaccines
Figure Pediatric Preventable Vaccines Product Picture
Table Major Manufacturers of Pediatric Preventable Vaccines
Table Global Preventable Vaccines Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Bacterial Diseases
Figure Virus Diseases
Figure Preventable Vaccines Report Years Considered
Figure Global Preventable Vaccines Market Size 2014-2025 (Million US$)
Figure Global Preventable Vaccines Sales 2014-2025 (K Units)
Table Global Preventable Vaccines Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Preventable Vaccines Sales by Regions 2014-2019 (K Units)
Table Global Preventable Vaccines Sales Market Share by Regions 2014-2019
Figure Global Preventable Vaccines Sales Market Share by Regions 2014-2019
Figure 2018 Global Preventable Vaccines Sales Market Share by Regions
Table Global Preventable Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global Preventable Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Preventable Vaccines Revenue Market Share by Regions 2014-2019
Figure 2018 Global Preventable Vaccines Revenue Market Share by Regions
Table Global Preventable Vaccines Sales by Manufacturers (2014-2019) (K Units)
Table Global Preventable Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global Preventable Vaccines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Preventable Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table Preventable Vaccines Revenue Share by Manufacturers (2014-2019)
Figure Preventable Vaccines Value Share by Manufacturers in 2018
Table Key Manufacturers Preventable Vaccines Price (2014-2019) (USD/Unit)
Table Preventable Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Preventable Vaccines Product Type
Table Date of International Manufacturers Enter into Preventable Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Preventable Vaccines Sales by Product (2014-2019) (K Units)
Table Global Preventable Vaccines Sales Share by Product (2014-2019)
Figure Global Preventable Vaccines Sales Market Share by Product (2014-2019)
Figure Global Preventable Vaccines Sales Market Share by Product in 2018
Table Global Preventable Vaccines Revenue by Product (2014-2019) (Million US$)
Table Global Preventable Vaccines Revenue Share by Product (2014-2019)
Figure Global Preventable Vaccines Revenue Market Share by Product (2014-2019)
Figure Global Preventable Vaccines Revenue Market Share by Product in 2018
Table Preventable Vaccines Price by Product 2014-2019 (USD/Unit)
Table Global Preventable Vaccines Sales by End User (2014-2019) (K Units)
Table Global Preventable Vaccines Sales Share by End User (2014-2019)
Figure Global Sales Preventable Vaccines Market Share by End User (2014-2019)
Figure Global Sales Preventable Vaccines Market Share by End User in 2018
Figure North America Preventable Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure North America Preventable Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America Preventable Vaccines Sales by Countries (2014-2019) (K Units)
Table North America Preventable Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 North America Preventable Vaccines Sales Market Share by Countries
Table North America Preventable Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America Preventable Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Preventable Vaccines Revenue Market Share by Countries
Figure United States Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure United States Preventable Vaccines Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Canada Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table North America Preventable Vaccines Sales by Product (2014-2019) (K Units)
Table North America Preventable Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 North America Preventable Vaccines Market Share by Product
Table North America Preventable Vaccines Sales by End User (2014-2019) (K Units)
Table North America Preventable Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 North America Preventable Vaccines Market Share by End User
Figure Europe Preventable Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Europe Preventable Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Preventable Vaccines Sales by Countries (2014-2019) (K Units)
Table Europe Preventable Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Preventable Vaccines Sales Market Share by Countries
Table Europe Preventable Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe Preventable Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Preventable Vaccines Revenue Market Share by Countries
Figure Germany Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Germany Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure France Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure France Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure UK Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Italy Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Russia Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Preventable Vaccines Sales by Product (2014-2019) (K Units)
Table Europe Preventable Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Europe Preventable Vaccines Market Share by Product
Table Europe Preventable Vaccines Sales by End User (2014-2019) (K Units)
Table Europe Preventable Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Europe Preventable Vaccines Market Share by End User
Figure Asia Pacific Preventable Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Preventable Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Preventable Vaccines Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Preventable Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Preventable Vaccines Sales Market Share by Countries
Table Asia Pacific Preventable Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Preventable Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Preventable Vaccines Revenue Market Share by Countries
Figure China Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure China Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Japan Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Korea Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure India Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Australia Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Preventable Vaccines Sales by Product (2014-2019) (K Units)
Table Asia Pacific Preventable Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Preventable Vaccines Market Share by Product
Table Asia Pacific Preventable Vaccines Sales by End User (2014-2019) (K Units)
Table Asia Pacific Preventable Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Preventable Vaccines Market Share by End User
Figure Central & South America Preventable Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Preventable Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Preventable Vaccines Sales by Countries (2014-2019) (K Units)
Table Central & South America Preventable Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Preventable Vaccines Sales Market Share by Countries
Table Central & South America Preventable Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Preventable Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Preventable Vaccines Revenue Market Share by Countries
Figure Brazil Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Preventable Vaccines Sales by Product (2014-2019) (K Units)
Table Central & South America Preventable Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Preventable Vaccines Market Share by Product
Table Central & South America Preventable Vaccines Sales by End User (2014-2019) (K Units)
Table Central & South America Preventable Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Preventable Vaccines Market Share by End User
Figure Middle East and Africa Preventable Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Preventable Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Preventable Vaccines Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Preventable Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Preventable Vaccines Sales Market Share by Countries
Table Middle East and Africa Preventable Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Preventable Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Preventable Vaccines Revenue Market Share by Countries
Figure GCC Countries Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Preventable Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Preventable Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Preventable Vaccines Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Preventable Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Preventable Vaccines Market Share by Product
Table Middle East and Africa Preventable Vaccines Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Preventable Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Preventable Vaccines Market Share by End User
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Abbott Company Details
Table Abbott Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Recent Development
Table Roche Company Details
Table Roche Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Mitsubishi Tanabe Pharma Company Details
Table Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mitsubishi Tanabe Pharma Recent Development
Table Lupin Company Details
Table Serum Institute of India Company Details
Table LG Life Sciences Company Details
Table S K Chemicals Company Details
Table Shenzhen Kangtai Biological Products Company Details
Table Sinovac Biotech Company Details
Table Janssen Pharmaceuticals Company Details
Table Crucell Company Details
Table Bavarian Nordic Company Details
Table Baxter Company Details
Table Bharat Biotech Company Details
Table Dynavax Company Details
Table Valeant Pharmaceuticals Company Details
Table Protein Sciences Company Details
Table Panacea Biotec Company Details
Table Global Preventable Vaccines Sales Forecast by Regions 2019-2025 (K Units)
Table Global Preventable Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global Preventable Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Preventable Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table Global Preventable Vaccines Sales Forecast by Product 2019-2025 (K Units)
Table Global Preventable Vaccines Sales Market Share Forecast by Product 2019-2025
Table Global Preventable Vaccines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Preventable Vaccines Revenue Market Share Forecast by Product 2019-2025
Table Global Preventable Vaccines Sales Forecast by End User 2019-2025 (K Units)
Table Global Preventable Vaccines Sales Market Share Forecast by End User 2019-2025
Figure North America Preventable Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Preventable Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Preventable Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Preventable Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Preventable Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Preventable Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Preventable Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Preventable Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Preventable Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Preventable Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Preventable Vaccines Value Chain
Table Preventable Vaccines Customers List
Table Preventable Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Preventable Vaccines Market Insights, Forecast to 2025
GlaxoSmithKlineMerck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Valeant Pharmaceuticals
Protein Sciences
Panacea Biotec